Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia 42Breast Neoplasms 32Carcinoma, Non-Small-Cell Lung 22Leukemia, Myeloid, Acute 21Lung Neoplasms 19Congenital Abnormalities 17Kidney Neoplasms 16Rectal Neoplasms 15Lymphoma 15Head and Neck Neoplasms 15Colorectal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Melanoma 14Colonic Neoplasms 14Sarcoma 13Lymphoma, Follicular 11Carcinoma, Renal Cell 11Lymphoma, Large B-Cell, Diffuse 10Leukemia, Megakaryoblastic, Acute 10Prostatic Neoplasms 9Leukemia, Myelomonocytic, Acute 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 9Central Nervous System Neoplasms 9Multiple Myeloma 8Leukemia, Lymphocytic, Chronic, B-Cell 7Gliosarcoma 7Glioblastoma 7Esophageal Neoplasms 7

Interventions

liposomal doxorubicin 3Paclitaxel 3Thalidomide 2Semaxinib 2Polymerase Chain Reaction 2Filgrastim 2Etoposide 2Docetaxel 2Daunorubicin 2valspodar 1nirogacestat 1halofuginone 1etoposide phosphate 1entinostat 1emvododstat 1efineptakin alfa 1Valproic Acid 1Sunitinib 1Sirolimus 1Saquinavir 1SUB1 protein, human 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Palliative Care 1Nutritional Support 1Nelfinavir 1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3- dimethyl-L-Valinamide 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × Gene Expression Profiling × Clear all
NCT00686842 2018-06-06

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 1/2 Terminated
17 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡